Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
        • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
      • Recently Published Guidelines
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
      • Brigham and Women's Hospital
      • Hartford Hospital
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Instituto do Coração-INCOR (São Paulo, Brasil)
      • Minneapolis City Hospital
      • Parkland Hospital: Dallas, Texas
      • Pennsylvania Hospital, Philadelphia
      • Pitié-Salpêtrière Hospital
      • Royal Infirmary of Edinburgh, Scotland
      • Tufts Medical Center
      • University of Michigan
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
      • Women's College Hospital, Toronto, Canada
      • Henry Ford Hospital, Detroit, Michigan
      • Instituto Nacional de Cardiología Ignacio Chávez – INCICh México City, México
      • Kuang-Tien General Hospital (Taichug, Taiwan)
      • University Hospital “Policlinico Umberto I”
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Images in Cardiovascular Medicine

Fibrosing Mediastinitis

A Squeeze on Arterial and Venous Segments of the Heart

Mackram Eleid, Siva K. Mulpuru, Samuel J. Asirvatham, David R. Holmes
Download PDF
https://doi.org/10.1161/CIRCULATIONAHA.114.010166
Circulation. 2014;130:290-291
Originally published July 14, 2014
Mackram Eleid
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siva K. Mulpuru
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel J. Asirvatham
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David R. Holmes
From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

A 38-year-old woman developed fibrosing mediastinitis after an initial episode of histoplasmosis. She had history of frequent bronchitis as a teenager and developed symptoms suggestive of pneumonia unresponsive to conventional antibiotics. In addition to right lung infiltrates, she developed mediastinal lymphadenopathy. After transbronchial biopsy confirmation of histoplasmosis, she received therapy with oral itraconazole. Three years after her initial therapy with itraconazole, she presented with worsening dyspnea on exertion. Echocardiography suggested new-onset pulmonary hypertension and moderate tricuspid regurgitation. Cross-sectional imaging of the chest demonstrated thickened pleura and pericardium; calcified, enlarged lymph nodes; and prominent fibrosis in the hilar region. Thorascopic and mediastinoscopic biopsies confirmed the diagnosis of fibrosing mediastinitis. She was treated with courses of antibiotics and pulsed steroids over the years for symptoms of dyspnea, hemoptysis, and pleuritic chest pain associated with radiological evidence of disease progression. Notably, the steroids did not seem to change the disease progression.

Pulmonary function tests revealed a reduction in lung volumes with a severe reduction in diffusing capacity of the lung for carbon monoxide (DLco, 38% predicted after adjustment for hemoglobin). She developed exercise-induced oxygen desaturation and was treated with supplemental oxygen therapy. Evidence of right pulmonary artery stenosis and pulmonary vein stenosis was seen on contrast-enhanced computed tomography scan (Figure 1). The right-sided pulmonary veins were completely occluded, with significant stenosis in the left inferior pulmonary vein. Notably, the stenosis is in the intra-atrial segment and differs from venous segment stenosis caused by ablation procedures. Perfusion scan suggested a lack of flow to the right lung. 18-Flurodeoxyglucose positron emission tomography scan suggested minimal active inflammation in the mediastinum with enhancement of a single cardiac lymph node. She was tapered off steroids and was treated with balloon dilation (Movies I and II in the online only Data Supplement show before and after dilation), long-term anticoagulation, and oxygen therapy.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A, Computed tomography (CT) scan with contrast showing significant stenosis of the right pulmonary artery. B, Perfusion scan of the lungs showing absent perfusion to the right lung. C, 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging showing overall minimal enhancement in the mediastinum; however, increased uptake is seen on 1 of the cardiac lymph nodes. D, CT reconstruction of the left atrium (LA) showing completely occluded right-sided pulmonary veins and critical stenosis in the atrial component near the left inferior pulmonary vein. E, Pressure gradient improves after balloon dilatation of the left inferior pulmonary vein (PV).

Histoplasmosis is an endemic mycosis in North and Central America. Most patients can be asymptomatic. Pulmonary infiltrates with mediastinal lymphadenopathy should raise the suspicion for histoplasmosis. Diagnosis can be made rapidly by serological tests, staining, and culture of bronchoalveolar lavage fluid and, in rare cases, biopsy. Therapy with antifungal drugs can result in marked improvement of symptoms.1 Fibrosing mediastinitis is a rare complication of histoplasmosis. Dissemination of fungal antigens in the pulmonary reticulo-endothelial system leads to enlargement of lymph nodes. The lymph nodes coalesce and form inflamed caseous mass, which eventually leads to sclerosis of the mediastinal structures (Figure 2). Other rare causes of fibrosing mediastinitis include exposure to tuberculosis, aspergillosis, Wuchereria bancrofti, Blastomyces dermatitidis, and radiation therapy.2 Some forms of fibrosing mediastinitis are associated with autoimmune disorders. Mediastinal fibrosis can lead to obstruction of the hilar components, notably pulmonary veins, arteries, and bronchi. Superior vena caval and esophageal obstruction is often seen in these patients. Postobstructive necrotizing pneumonia and development of tracheo-esophageal fistula have been reported. Interventions to open the stenotic segments are often palliative. Steroids are useful only in the autoimmune form of fibrosing mediastinitis. Development of cor pulmonale or respiratory compromise is usually the terminal event.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Autopsy specimens of the right lung from patient with fibrosing mediastinitis after histoplasmosis. Note the narrowing of artery (A, red arrow) and vein (A, white arrow) with a close-up view in B. B, Stenosis is also noted in the bronchus, which is to the right and inferior to the pulmonary vein.

Acknowledgments

We thank William D. Edwards, MD, Anatomic Pathology, Mayo Clinic, for generously sharing the autopsy pictures.

Disclosures

Dr Mulpuru is supported by Department of Internal Medicine Career Development Grant. The other authors report no conflicts.

Footnotes

  • The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.114.010166/-/DC1.

  • © 2014 American Heart Association, Inc.

References

  1. 1.↵
    1. Wheat LJ,
    2. Freifeld AG,
    3. Kleiman MB,
    4. Baddley JW,
    5. McKinsey DS,
    6. Loyd JE,
    7. Kauffman CA
    . Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807–825.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Peikert T,
    2. Colby TV,
    3. Midthun DE,
    4. Pairolero PC,
    5. Edell ES,
    6. Schroeder DR,
    7. Specks U
    . Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore). 2011;90:412–423.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation
July 15, 2014, Volume 130, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Fibrosing Mediastinitis
    Mackram Eleid, Siva K. Mulpuru, Samuel J. Asirvatham and David R. Holmes
    Circulation. 2014;130:290-291, originally published July 14, 2014
    https://doi.org/10.1161/CIRCULATIONAHA.114.010166

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Fibrosing Mediastinitis
    (Your Name) has sent you a message from Circulation
    (Your Name) thought you would like to see the Circulation web site.
  • Share on Social Media
    Fibrosing Mediastinitis
    Mackram Eleid, Siva K. Mulpuru, Samuel J. Asirvatham and David R. Holmes
    Circulation. 2014;130:290-291, originally published July 14, 2014
    https://doi.org/10.1161/CIRCULATIONAHA.114.010166
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Intervention, Surgery, Transplantation
    • Treatment
  • Imaging and Diagnostic Testing
    • Computerized Tomography (CT)

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured